Neos Therapeutics to Host Fourth Quarter and Year-End 2017 Financial Results Conference Call on March 15, 2017
March 08 2018 - 7:30AM
Neos Therapeutics, Inc. (NASDAQ:NEOS), a pharmaceutical company
focused on developing, manufacturing and commercializing innovative
extended-release (XR) products using its proprietary
modified-release drug delivery and orally disintegrating tablet
(ODT) technology platforms, today announced that it will report
fourth quarter and year-end 2017 financial results prior to the
opening of U.S. financial markets on Thursday, March 15, 2017. Neos
management will host a conference call and live audio webcast to
discuss these results and provide a company update at 8:30 a.m. ET
that same day.
The live call may be accessed by dialing (877)
388-8985 for domestic calls, or +1 (562) 912-2654 for international
callers, and referencing conference ID number 5653457. A live audio
webcast for the conference call will be available on the Investor
Relations page of the company’s website at
http://investors.neostx.com/.
About Neos Therapeutics
Neos Therapeutics, Inc. (NASDAQ:NEOS) is a
pharmaceutical company focused on developing, manufacturing and
commercializing products utilizing its proprietary modified-release
drug delivery technology platforms. Adzenys XR-ODT® (amphetamine)
extended-release orally disintegrating tablets (see Full
Prescribing Information, including Boxed WARNING), Cotempla XR-ODT™
(methylphenidate) extended-release orally disintegrating tablets
(see Full Prescribing Information, including Boxed WARNING), and
Adzenys-ER™ (amphetamine) extended-release oral suspension (see
Full Prescribing Information, including Boxed WARNING), all for the
treatment of ADHD, are the first three approved products using the
Company’s extended-release technology platform. Additional
information about Neos is available at www.neostx.com.
Contacts:
Richard EisenstadtChief Financial OfficerNeos Therapeutics(972)
408-1389reisenstadt@neostx.com
Sarah McCabeSenior Vice PresidentStern Investor Relations,
Inc.(212) 362-1200sarah@sternir.com
Neos Therapeutics (NASDAQ:NEOS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Neos Therapeutics (NASDAQ:NEOS)
Historical Stock Chart
From Apr 2023 to Apr 2024